SCHEMBL6201869

SCHEMBL6201869

CN(C)C(C=O)CS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19955410 1.00
SCHEMBL20411705 0.74
SCHEMBL3641666 0.74
SCHEMBL6204289 0.74 FDPS (0.31)
SCHEMBL9240887 0.72
SCHEMBL10583046 0.72
SCHEMBL27281782 0.72
SCHEMBL20767759 0.72
SCHEMBL15203093 0.70
SCHEMBL21621642 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1503994-A1 SUBSTITUTED (THIOXO)CARBONYLAMINO PHENYL URACILES Bayer CropScience AG (DE) 2005-02-09 EP disclosed
WO-2003093244-A1 SUBSTITUTED (THIOXO)CARBONYLAMINO PHENYL URACILES BAYER CROPSCIENCE AG (DE) 2003-11-13 WO disclosed
US-6552007-B2 A conjugate of somatostatin analog-spacer-anticarcinogenic agent increases the specificity on targeted tumor cells, thus reducing side effects; drug delivery; e.g., octreotide-CO-CH2-CH2-(O-CH2-CH2)(1-7)-CO-paclitaxel ACADEMIA SINICA (TW) 2003-04-22 US disclosed